<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335905">
  <stage>Registered</stage>
  <submitdate>12/11/2010</submitdate>
  <approvaldate>15/11/2010</approvaldate>
  <actrnumber>ACTRN12610000982011</actrnumber>
  <trial_identification>
    <studytitle>Using ultrasound to measure the flow of eye blood vessel (Central Retinal Vein) to assess hydration status</studytitle>
    <scientifictitle>In adult pre-operative patients undergoing ocular doppler exam and echocardiography, what is the degree of correlation between Central Retinal Venous flow velocity and Left Ventricular End-Diastolic Area Index?</scientifictitle>
    <utrn>U1111-1116-7469</utrn>
    <trialacronym>CREVOL</trialacronym>
    <secondaryid>HREC/10/QPAH/188</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Intra-vascular volume status</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Normal development and function of the cardiovascular system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>After obtaining informed consent, the patient's height and weight are recorded. Then the patient is asked to lie supine. ECG dots are placed on the chest to time Echocardiography as per the normal routine. A clear occlusive shield is placed over one eye and an Doppler Ultrasound probe is placed. The Maximum and Minimum flow velocities of the Central Retinal Vein is measured for four cardiac cycles. Then the occlusive shield is removed. This procedure takes approximately 10 minutes.</interventions>
    <comparator>A limited trans-thoracic Echocardiogram is performed - An Echocardiography probe is placed over the left side of the sternum after applying conductive gel. A parasternal short axis view of the Left Ventricle is obtained. The left ventricular end diastolic area is recorded for four cardiac cycles. The whole exam takes approximately 10 minutes.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Degree of correlation between the Central retinal venous flow velocity and the Left ventricular end-diastolic area index</outcome>
      <timepoint>Nil</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult patients (18 years of age and above), who present for undergoing elective surgery at the QE II Jubilee hospital, Coopers plains, QLD 4108, Australia.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Pre existing eye diseases like documented Diabetic and hypertensive complications in the eye (Diabetes Mellitus and Hypertension per se do not exclude the patient). 2. Glaucoma 3. Patients who have sustained Eye injuries 4. Patients presenting for Eye surgery 5. Patients who had previous eye surgeries other than uncomplicated cataract removal and minor eye procedures 6. Any other contra-indication to performing a routine ocular Doppler examination 7. Patients presenting for Emergency surgeries 8. Evidence of Increased Intra-cranial pressure 9. History of Epilepsy 10. Patients with evidence of heart failure 11. Pregnant women 12. Children 13. Patients who refuse consent.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>All patients belong to only one group. There is no outcome comparison involved.</concealment>
    <sequence>No randomization</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>12/11/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>47</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>QE II JUBILEE HOSPITAL - DEPT. OF ANAESTHESIA</primarysponsorname>
    <primarysponsoraddress>CNR KESSELS RD AND TROUGHTON ST
COOPERS PLAINS
QLD 4108</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to test a simple and non-invasive method for estimating intravascular volume status. Estimation of intravascular volume status (hydration status) is of crucial importance in treating patients in various specialties including intensive care. The current methods available are mostly invasive. The non-invasive methods currently in vogue are resource intensive. Hence, there is a need for a simple, consistent and reliable measure for assessment of intravascular volume status. With this view, this study proposes the use of Central Retinal Venous blood flow velocity as an index of intravascular volume status.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>METRO SOUTH HEALTH SERVICE DISTRICT (EC00167)</ethicname>
      <ethicaddress>Centres for Health Research (Contracts)
Level 2, Building 35
Princess Alexandra Hospital
199 Ipswich Road Woolloongabba, Brisbane, Queensland, 4102, AUSTRALIA
Tel:  07 3176 2115
Tel: 07 3176 7672
FAX: 07 3176 7667</ethicaddress>
      <ethicapprovaldate>10/11/2010</ethicapprovaldate>
      <hrec>HREC/10/QPAH/188</hrec>
      <ethicsubmitdate>20/08/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>DR. BALAJI BIKSHANDI</name>
      <address>9/200 Jackson Road
Sunnybank Hills
QLD 4109</address>
      <phone>+61 7 3344 1971</phone>
      <fax />
      <email>balaji.md@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>DR. BALAJI BIKSHANDI</name>
      <address>DEPT. OF ANAESTHESIA
QE II JUBILEE HOSPITAL
COOPERS PLAINS
QLD 4108</address>
      <phone>+61 7 3275 6111</phone>
      <fax />
      <email>balaji.md@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>DR. BALAJI BIKSHANDI</name>
      <address>9/200 Jackson Road
Sunnybank Hills
QLD 4109</address>
      <phone>07 3344 1971</phone>
      <fax />
      <email>balaji.md@gmail.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>